These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17164694)

  • 41. Serum metabolite/caffeine ratios as a test for liver function.
    Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
    J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic and pharmacodynamic interactions of propafenone and cimetidine.
    Pritchett EL; Smith WM; Kirsten EB
    J Clin Pharmacol; 1988 Jul; 28(7):619-24. PubMed ID: 3063727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic interactions between phenylpropanolamine, caffeine and chlorpheniramine in rats.
    Kaddoumi A; Nakashima MN; Wada M; Nakashima K
    Eur J Pharm Sci; 2004 Jun; 22(2-3):209-16. PubMed ID: 15158906
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of diprafenone on the pharmacokinetics of digoxin.
    Koytchev R; Alken RG; Mayer O
    Eur J Clin Pharmacol; 1996; 50(1-2):97-100. PubMed ID: 8739818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonidine disposition in children; a population analysis.
    Potts AL; Larsson P; Eksborg S; Warman G; Lönnqvist PA; Anderson BJ
    Paediatr Anaesth; 2007 Oct; 17(10):924-33. PubMed ID: 17767627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic properties and tolerability of bevirimat and atazanavir in healthy volunteers: an open-label, parallel-group study.
    Martin DE; Galbraith H; Schettler J; Ellis C; Doto J
    Clin Ther; 2008 Oct; 30(10):1794-805. PubMed ID: 19014835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction between warfarin and propafenone in healthy volunteer subjects.
    Kates RE; Yee YG; Kirsten EB
    Clin Pharmacol Ther; 1987 Sep; 42(3):305-11. PubMed ID: 3621785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
    Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of oral contraceptives on the pharmacokinetics of melatonin in healthy subjects with CYP1A2 g.-163C>A polymorphism.
    Hilli J; Korhonen T; Turpeinen M; Hokkanen J; Mattila S; Laine K
    J Clin Pharmacol; 2008 Aug; 48(8):986-94. PubMed ID: 18490497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinically significant pharmacokinetic interactions between dietary caffeine and medications.
    Carrillo JA; Benitez J
    Clin Pharmacokinet; 2000 Aug; 39(2):127-53. PubMed ID: 10976659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of CYP1A2 in caffeine pharmacokinetics and metabolism: studies using mice deficient in CYP1A2.
    Buters JT; Tang BK; Pineau T; Gelboin HV; Kimura S; Gonzalez FJ
    Pharmacogenetics; 1996 Aug; 6(4):291-6. PubMed ID: 8873215
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.
    Csajka C; Haller CA; Benowitz NL; Verotta D
    Br J Clin Pharmacol; 2005 Mar; 59(3):335-45. PubMed ID: 15752380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Integrated in vitro analysis for the in vivo prediction of cytochrome P450-mediated drug-drug interactions.
    McGinnity DF; Waters NJ; Tucker J; Riley RJ
    Drug Metab Dispos; 2008 Jun; 36(6):1126-34. PubMed ID: 18356267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic characterization of the antiarrhythmic drug diprafenone in man.
    Trenk D; Wagner F; Sachs W; Jähnchen E
    Eur J Clin Pharmacol; 1989; 37(3):313-6. PubMed ID: 2612546
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of short-term starvation or water deprivation on caffeine pharmacokinetics in calves.
    Janus K; Antoszek J; Suszycki S
    Res Vet Sci; 2001 Apr; 70(2):109-13. PubMed ID: 11356089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.
    Panhard X; Legrand M; Taburet AM; Diquet B; Goujard C; Mentré F;
    Eur J Clin Pharmacol; 2007 Nov; 63(11):1019-29. PubMed ID: 17694300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single-dose interaction study of diprafenone HCl and propranolol HCl in healthy volunteers.
    Hinderling PH; Tendolkar A; Dee CM; Barr WH; Seiberling M; Duerr H
    J Clin Pharmacol; 1995 Jul; 35(7):721-9. PubMed ID: 7560253
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ECG changes and plasma concentrations of propafenone and its metabolites in a case of severe poisoning.
    Fonck K; Haenebalcke C; Hemeryck A; Belpaire F; Jordaens L; Calle P; Buylaert W
    J Toxicol Clin Toxicol; 1998; 36(3):247-51. PubMed ID: 9656983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intra-individual variability of caffeine elimination in healthy subjects.
    Balogh A; Harder S; Vollandt R; Staib AH
    Int J Clin Pharmacol Ther Toxicol; 1992 Oct; 30(10):383-7. PubMed ID: 1304170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.